{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:47:47Z","timestamp":1787028467615,"version":"build-2736575974"},"reference-count":130,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-15-00042"],"award-info":[{"award-number":["21-15-00042"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Latent tuberculosis infection (LTBI) represents a major challenge to curing TB disease. Current guidelines for LTBI management include only three older drugs and their combinations\u2014isoniazid and rifamycins (rifampicin and rifapentine). These available control strategies have little impact on latent TB elimination, and new specific therapeutics are urgently needed. In the present mini-review, we highlight some of the alternatives that may potentially be included in LTBI treatment recommendations and a list of early-stage prospective small molecules that act on drug targets specific for Mycobacterium tuberculosis latency.<\/jats:p>","DOI":"10.3390\/ijms222413317","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T01:28:11Z","timestamp":1639358891000},"page":"13317","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-2421","authenticated-orcid":false,"given":"Anna","family":"Egorova","sequence":"first","affiliation":[{"name":"The Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Center of Biotechnology RAS), 119071 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-6598","authenticated-orcid":false,"given":"Elena G.","family":"Salina","sequence":"additional","affiliation":[{"name":"The Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Center of Biotechnology RAS), 119071 Moscow, Russia"},{"name":"Department of Biology and Biotechnology \u201cLazzaro Spallanzani\u201d, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[{"name":"The Federal Research Centre \u201cFundamentals of Biotechnology\u201d of the Russian Academy of Sciences (Research Center of Biotechnology RAS), 119071 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021, September 15). The top 10 causes of death. Available online: Who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"key":"ref_2","unstructured":"WHO (2020). Global Tuberculosis Report 2020, World Health Organization."},{"key":"ref_3","unstructured":"WHO (2019). Global Tuberculosis Report 2019, World Health Organization."},{"key":"ref_4","unstructured":"WHO (2018). Global Tuberculosis Report 2018, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a017830","DOI":"10.1101\/cshperspect.a017830","article-title":"Diagnosis and Management of Latent Tuberculosis Infection","volume":"5","author":"Stagg","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_6","unstructured":"WHO (2018). Latent Tuberculosis Infection\u2014Executive Summary, World Health Organization."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: A systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_8","unstructured":"WHO (2018). Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management, World Health Organization."},{"key":"ref_9","first-page":"483","article-title":"The challenge of new drug discovery for tuberculosis","volume":"469","author":"Koul","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: Confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.104.5.737","article-title":"Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy","volume":"104","author":"McCune","year":"1956","journal-title":"J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.123.3.445","article-title":"Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues","volume":"123","author":"McCune","year":"1966","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","article-title":"Mouse models of human TB pathology: Roles in the analysis of necrosis and the development of host-directed therapies","volume":"38","author":"Kramnik","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tube.2008.08.004","article-title":"Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model","volume":"89","author":"Kesavan","year":"2009","journal-title":"Tuberculosis"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/AAC.00276-07","article-title":"Location of persisting mycobacteria in a guinea pig model of tuberculosis revealed by r207910","volume":"51","author":"Lenaerts","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model","volume":"77","author":"Lin","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tim.2017.08.001","article-title":"Opening Pandora\u2019s Box: Mechanisms of Mycobacterium tuberculosis Resuscitation","volume":"26","author":"Veatch","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1128\/JB.182.22.6358-6365.2000","article-title":"Detection of mRNA Transcripts and Active Transcription in Persistent Mycobacterium tuberculosis Induced by Exposure to Rifampin or Pyrazinamide","volume":"182","author":"Hu","year":"2000","journal-title":"J. Bacteriol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/00221287-148-5-1581","article-title":"Formation and resuscitation of \u2018non-culturable\u2019 cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase","volume":"148","author":"Shleeva","year":"2002","journal-title":"Microbiology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Deb, C., Lee, C.-M., Dubey, V.S., Daniel, J., Abomoelak, B., Sirakova, T.D., Pawar, S., Rogers, L., and Kolattukudy, P.E. (2009). A Novel In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006077"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/AAC.00821-10","article-title":"Simple Model for Testing Drugs against Nonreplicating Mycobacterium tuberculosis","volume":"54","author":"Sala","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tube.2010.12.006","article-title":"Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification","volume":"91","author":"Shleeva","year":"2011","journal-title":"Tuberculosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/AAC.01308-13","article-title":"New 2-Thiopyridines as Potential Candidates for Killing both Actively Growing and Dormant Mycobacterium tuberculosis Cells","volume":"58","author":"Salina","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for latent tuberculosis infection: New alternatives","volume":"11","author":"Carranza","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_27","first-page":"376","article-title":"Clemens von Pirquet: A Remarkable Life and Career","volume":"6","author":"Shulman","year":"2016","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)74210-3","article-title":"Treatment of staphylococcal infections with penicillin by intermittent sterilization","volume":"244","author":"Bigger","year":"1944","journal-title":"Lancet"},{"key":"ref_29","first-page":"257","article-title":"Microbial persistence","volume":"30","author":"McDedmott","year":"1958","journal-title":"Yale J. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gold, B., and Nathan, C. (2017). Targeting Phenotypically Tolerant Mycobacterium tuberculosis. Microbiol. Spectr., 5.","DOI":"10.1128\/microbiolspec.TBTB2-0031-2016"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/378240","article-title":"Stability of DNA Patterns and Evidence of Mycobacterium tuberculosis Reactivation Occurring Decades after the Initial Infection","volume":"188","author":"Lillebaek","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Colangeli, R., Arcus, V.L., Cursons, R.T., Ruthe, A., Karalus, N., Coley, K., Manning, S.D., Kim, S., Marchiano, E., and Alland, D. (2014). Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091024"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dhar, N., McKinney, J., and Manina, G. (2016). Phenotypic Heterogeneity in Mycobacterium tuberculosis. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.TBTB2-0021-2016"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/814943","article-title":"Pathogenesis, Immunology, and Diagnosis of Latent Mycobacterium tuberculosis Infection","volume":"2011","author":"Ahmad","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1183\/09031936.04.00072604","article-title":"On the nature of Mycobacterium tuberculosis-latent bacilli","volume":"24","author":"Cardona","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3389\/fimmu.2018.02108","article-title":"The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity","volume":"9","author":"Hunter","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gibson, S., Harrison, J., and Cox, J. (2018). Modelling a Silent Epidemic: A Review of the In Vitro Models of Latent Tuberculosis. Pathogens, 7.","DOI":"10.20944\/preprints201810.0701.v2"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/AAC.00055-06","article-title":"Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis","volume":"51","author":"Cho","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/jb.26.2.139-166.1933","article-title":"The Influence of Foodstuffs upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli","volume":"26","author":"Loebel","year":"1933","journal-title":"J. Bacteriol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1128\/AAC.01125-12","article-title":"Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis","volume":"56","author":"Zhang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","first-page":"4","article-title":"Experimental studies on the mechanism of infection and immunity in tuberculosis from the analytical standpoint of streptomycin-dependent tubercle bacilli. 1. Isolation and biological characteristics of a streptomycin-dependent mutant, and effect of streptomycin administration on its pathogenicity in guinea pigs","volume":"30","author":"Hashimoto","year":"1955","journal-title":"Kekkaku"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"613149","DOI":"10.3389\/fcimb.2021.613149","article-title":"One size fits all? Not in in vivo modeling of tuberculosis chemotherapeutics","volume":"11","author":"Yang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/82139","article-title":"Latent Mycobacterium tuberculosis\u2013persistence, patience and winning by waiting","volume":"6","author":"Manabe","year":"2000","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20040646","article-title":"Dormancy Phenotype Displayed by Extracellular Mycobacterium tuberculosis within Artificial Granulomas in Mice","volume":"200","author":"Karakousis","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/microbiolspec.TBTB2-0034-2017","article-title":"Preclinical Efficacy Testing of New Drug Candidates","volume":"5","author":"Nuermberger","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1472-9792(02)00059-8","article-title":"Non-human primates: A model for tuberculosis research","volume":"83","author":"Flynn","year":"2003","journal-title":"Tuberculosis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4046\/trd.2017.0052","article-title":"Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy","volume":"81","author":"Kim","year":"2018","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QCO.0000000000000253","article-title":"Diagnosis and management of latent tuberculosis","volume":"29","author":"Turetz","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.jmb.2019.02.016","article-title":"The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis","volume":"431","author":"Jacobs","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M803899200","article-title":"Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis","volume":"283","author":"Koul","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1128\/AAC.05293-11","article-title":"Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis","volume":"55","author":"Tasneen","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1164\/rccm.201103-0397OC","article-title":"Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection","volume":"184","author":"Zhang","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_56","first-page":"962","article-title":"A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis","volume":"405","author":"Stover","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/AAC.49.6.2294-2301.2005","article-title":"Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models","volume":"49","author":"Lenaerts","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","article-title":"PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release","volume":"322","author":"Singh","year":"2008","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.ajpath.2014.03.008","article-title":"Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice","volume":"184","author":"Dutta","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2014.07.012","article-title":"PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB\/FeJ mice","volume":"44","author":"Dutta","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e02402-16","DOI":"10.1128\/AAC.02402-16","article-title":"Delamanid Kills Dormant Mycobacteria In Vitro and in a Guinea Pig Model of Tuberculosis","volume":"61","author":"Chen","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.tube.2021.102089","article-title":"Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis","volume":"128","author":"Branco","year":"2021","journal-title":"Tuberculosis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1002\/slct.202004724","article-title":"Sacubitril-Based Urea and Thiourea Derivatives as Novel Inhibitors for Anti-Tubercular against Dormant Tuberculosis","volume":"6","author":"Konduri","year":"2021","journal-title":"ChemistrySelect"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1016\/j.bmc.2018.07.034","article-title":"An antimycobacterial pleuromutilin analogue effective against dormant bacilli","volume":"26","author":"Lemieux","year":"2018","journal-title":"Bioorganic Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms","volume":"78","author":"Dutta","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12706","DOI":"10.1073\/pnas.221272198","article-title":"Mycobacterium tuberculosis signal transduction system required for persistent infections","volume":"98","author":"Zahrt","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","first-page":"93","article-title":"Signal transduction systems of mycobacteria with special reference to M. tuberculosis","volume":"86","author":"Tyagi","year":"2004","journal-title":"Curr. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1128\/IAI.01449-08","article-title":"Unique Roles of DosT and DosS in DosR Regulon Induction and Mycobacterium tuberculosis Dormancy","volume":"77","author":"Honaker","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/bios3030259","article-title":"The DosS-DosT\/DosR mycobacterial sensor system","volume":"3","author":"Sivaramakrishnan","year":"2013","journal-title":"Biosensors"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1128\/JB.00550-10","article-title":"Different Roles of DosS and DosT in the Hypoxic Adaptation of Mycobacteria","volume":"192","author":"Kim","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1021\/jm900358q","article-title":"Structure-Based Design of DevR Inhibitor Active against Nonreplicating Mycobacterium tuberculosis","volume":"52","author":"Gupta","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio.2259","article-title":"Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence","volume":"13","author":"Zheng","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1574-6976.1996.tb00247.x","article-title":"Bacterial aminopeptidases: Properties and functions","volume":"18","author":"Gonzales","year":"1996","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chembiol.2009.12.014","article-title":"Methionine Aminopeptidases from Mycobacterium tuberculosis as Novel Antimycobacterial Targets","volume":"17","author":"Olaleye","year":"2010","journal-title":"Chem. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.tube.2016.09.025","article-title":"Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis","volume":"101","author":"John","year":"2016","journal-title":"Tuberculosis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.tube.2011.10.012","article-title":"Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis","volume":"91","author":"Olaleye","year":"2011","journal-title":"Tuberculosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/DDDT.S238148","article-title":"Pre-clinical pharmacokinetics, tissue distribution and physicochemical studies of CLBQ14, a novel methionine aminopeptidase inhibitor for the treatment of infectious diseases","volume":"14","author":"Ekpenyong","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"19695","DOI":"10.1038\/srep19695","article-title":"Mycobacterium lysine \u03b5-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level","volume":"6","author":"Duan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.chembiol.2018.09.009","article-title":"A Lysine Acetyltransferase Contributes to the Metabolic Adaptation to Hypoxia in Mycobacterium tuberculosis","volume":"25","author":"Rittershaus","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.tube.2015.04.010","article-title":"Discovery of novel lysine \u03b5-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis","volume":"95","author":"Devi","year":"2015","journal-title":"Tuberculosis"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/cbdd.12655","article-title":"Design and development of Mycobacterium tuberculosis lysine \u03b5-aminotransferase inhibitors for latent tuberculosis infection","volume":"87","author":"Parthiban","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bmc.2017.03.053","article-title":"Mycobacterium tuberculosis lysine-\u03b5-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors","volume":"25","author":"Reshma","year":"2017","journal-title":"Bioorganic Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.bmc.2017.12.044","article-title":"Synthesis and evaluation of 4\u2032,5\u2032-dihydrospiro[piperidine-4,7\u2032-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis","volume":"26","author":"Alluri","year":"2018","journal-title":"Bioorganic Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/JB.181.23.7161-7167.1999","article-title":"Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis","volume":"181","author":"Miczak","year":"1999","journal-title":"J. Bacteriol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1073\/pnas.1706134114","article-title":"Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis","volume":"114","author":"Pham","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/35021074","article-title":"Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase","volume":"406","author":"McKinney","year":"2000","journal-title":"Nature"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm1252","article-title":"Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence","volume":"11","author":"McKinney","year":"2005","journal-title":"Nat. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1099\/mic.0.033084-0","article-title":"Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability","volume":"156","author":"Gengenbacher","year":"2009","journal-title":"Microbiology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/77964","article-title":"Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis","volume":"7","author":"Sharma","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1039\/D0MD00301H","article-title":"Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase","volume":"12","author":"Kwai","year":"2020","journal-title":"RSC Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.drudis.2017.04.012","article-title":"Targeting isocitrate lyase for the treatment of latent tuberculosis","volume":"22","author":"Bhusal","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tube.2012.06.001","article-title":"Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase","volume":"92","author":"Trejtnar","year":"2012","journal-title":"Tuberculosis"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2015.12.003","article-title":"Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis","volume":"97","author":"Liu","year":"2016","journal-title":"Tuberculosis"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"111578","DOI":"10.1016\/j.ejmech.2019.111578","article-title":"Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds","volume":"181","author":"Baranyai","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/acschembio.0c00740","article-title":"Covalent inactivation of Mycobacterium tuberculosis isocitrate lyase by cis-2,3-epoxy-succinic acid","volume":"16","author":"Pham","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.chembiol.2012.09.018","article-title":"Structure-Guided Discovery of Phenyl-diketo Acids as Potent Inhibitors of M. tuberculosis Malate Synthase","volume":"19","author":"Krieger","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E2225","DOI":"10.1073\/pnas.1617655114","article-title":"Glyoxylate detoxification is an essential function of malate synthase required for carbon assimilation in Mycobacterium tuberculosis","volume":"114","author":"Puckett","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12275-019-8543-7","article-title":"Alanine dehydrogenases in mycobacteria","volume":"57","author":"Jeong","year":"2019","journal-title":"J. Microbiol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Giffin, M.M., Shi, L., Gennaro, M.L., and Sohaskey, C.D. (2016). Role of alanine dehydrogenase of Mycobacterium tuberculosis during recovery from hypoxic nonreplicating persistence. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155522"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2014.12.046","article-title":"Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors","volume":"92","author":"Saxena","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.bmc.2016.07.051","article-title":"Design and development of new class of Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors","volume":"24","author":"Reshma","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1016\/j.bmc.2016.09.012","article-title":"Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d ]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis","volume":"24","author":"Samala","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bbapap.2014.11.010","article-title":"Pyridoxal-phosphate dependent mycobacterial cysteine synthases: Structure, mechanism and potential as drug targets","volume":"1854","author":"Schnell","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1128\/JB.185.22.6736-6740.2003","article-title":"Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman","volume":"185","author":"Sareen","year":"2003","journal-title":"J. Bacteriol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1021\/acs.jmedchem.6b00674","article-title":"Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis","volume":"59","author":"Brunner","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1016\/j.bmcl.2017.08.039","article-title":"Profiling of in vitro activities of urea-based inhibitors against cysteine synthases from Mycobacterium tuberculosis","volume":"27","author":"Brunner","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/1574-6976.12087","article-title":"Metal limitation and toxicity at the interface between host and pathogen","volume":"38","author":"Becker","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/AAC.01289-15","article-title":"Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics","volume":"59","author":"Djoko","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1039\/C4MT00327F","article-title":"Copper tolerance and virulence in bacteria","volume":"7","author":"Ladomersky","year":"2015","journal-title":"Metallomics"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imr.12265","article-title":"Mycobacteria, metals, and the macrophage","volume":"264","author":"Neyrolles","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tube.2011.12.006","article-title":"Resistance mechanisms of Mycobacterium tuberculosis against phagosomal copper overload","volume":"92","author":"Rowland","year":"2012","journal-title":"Tuberculosis"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1039\/C8MT00067K","article-title":"Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones","volume":"10","author":"Salina","year":"2018","journal-title":"Metallomics"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1073\/pnas.0812808106","article-title":"The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity","volume":"106","author":"Macomber","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JB.00058-10","article-title":"Copper Stress Affects Iron Homeostasis by Destabilizing Iron-Sulfur Cluster Formation in Bacillus subtilis","volume":"192","author":"Chillappagari","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1039\/C5MT00011D","article-title":"Copper intoxication inhibits aerobic nucleotide synthesis in Streptococcus pneumonia","volume":"7","author":"Johnson","year":"2015","journal-title":"Metallomics"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.bmcl.2016.03.066","article-title":"Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis","volume":"26","author":"Torres","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1128\/AAC.00998-16","article-title":"In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium","volume":"60","author":"Nikonenko","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2019.05.082","article-title":"Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis","volume":"178","author":"Karale","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Bonnett, S.A., Dennison, D., Files, M., Bajpai, A., and Parish, T. (2018). A class of hydrazones are active against non-replicating Mycobacterium tuberculosis. PLoS ONE, 13.","DOI":"10.1101\/323220"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"112010","DOI":"10.1016\/j.ejmech.2019.112010","article-title":"Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity","volume":"188","author":"Sirim","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsinfecdis.0c00622","article-title":"Design and synthesis of pyrano[3,2-b]indolones showing antimycobacterial activity","volume":"7","author":"Monakhova","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jgar.2021.03.015","article-title":"In vitro potency of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione against drug-resistant and non-replicating persisters of Mycobacterium tuberculosis","volume":"25","author":"Rather","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"112178","DOI":"10.1016\/j.ejmech.2020.112178","article-title":"Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors","volume":"193","author":"Krishna","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/acsomega.0c05690","article-title":"Design and Synthesis of \u201cChloropicolinate Amides and Urea Derivatives\u201d as Novel Inhibitors for Mycobacterium tuberculosis","volume":"6","author":"Konduri","year":"2021","journal-title":"ACS Omega"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"127512","DOI":"10.1016\/j.bmcl.2020.127512","article-title":"Design and synthesis of purine connected piperazine derivatives as novel inhibitors of Mycobacterium tuberculosis","volume":"30","author":"Konduri","year":"2020","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1080\/07391102.2020.1797534","article-title":"Designing novel inhibitors against cyclopropane mycolic acid synthase 3 (PcaA): Targeting dormant state of Mycobacterium tuberculosis","volume":"39","author":"Verma","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.3389\/fmicb.2019.03154","article-title":"Clinical Development of New TB Vaccines: Recent Advances and Next Steps","volume":"10","author":"Hatherill","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG Vaccine against Tuberculosis: A Systematic Review of Randomized Controlled Trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e00973-21","DOI":"10.1128\/mBio.00973-21","article-title":"Toward a phage cocktail for tuberculosis: Susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains","volume":"12","author":"Dedrick","year":"2021","journal-title":"mBio"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/24\/13317\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:45:22Z","timestamp":1760168722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/24\/13317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":130,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222413317"],"URL":"https:\/\/doi.org\/10.3390\/ijms222413317","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]}}}